The Global Cognitive Impairment Associated With Schizophrenia (CIAS) Market is driven by increasing prevalence of schizophrenia
Cognitive impairment associated with schizophrenia (CIAS) refers to deficits in cognitive functions such as attention, working memory, verbal learning, social cognition, and executive functioning commonly seen in patients with schizophrenia. Schizophrenia is a severe mental disorder involving disturbances in thought, perception, emotions, language, sense of self and behavior. The symptoms of CIAS include dysfunctional memory, inability to focus, lack of abstract thinking and impaired communication skills.
The Global Cognitive Impairment Associated With Schizophrenia (CIAS) Market is estimated to be valued at USD 5.2 Bn in 2024 and is expected to reach USD 7.1 Bn by 2031, growing at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2031.
Growing prevalence of schizophrenia globally is driving the demand for drugs and therapies to treat cognitive dysfunctions resulting from the mental disorder. According to WHO, around 24 million people worldwide suffer from Cognitive Impairment Associated With Schizophrenia (CIAS) Market.
Get more insights on: Cognitive Impairment Associated With Schizophrenia (CIAS) Market
Get this Report in Japanese Language: 統合失調症に伴う認知機能障害（CIAS）市場
Get this Report in Korean Language: 정신분열증과 관련된 인지 장애(CIAS) 시장
Explore more related articles - Satellite as a Service: The Emerging Trend in Space Technology
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian